CANNAPHARMARX, INC.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2012
FY2011
FY2010
Asset Breakdown FY2023
Total Assets: $11.7M
Liabilities Breakdown FY2023
Total Liabilities: $23.9M
Asset Breakdown
Total Assets: $11.7M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $650 | 0.0% |
| Accounts Receivable | $0 | 0.0% |
| Inventory | $1.1M | 9.7% |
| Property, Plant & Equipment | $161.5K | 1.4% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $10.4M | 89.0% |
Liabilities Breakdown
Total Liabilities: $23.9M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $4.9M | 20.6% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $19.0M | 79.4% |